ID   CT3 [Mouse hybridoma against human GPC2]
AC   CVCL_E8D5
DR   ABCD; ABCD_BF001
RX   Patent=US12012463;
RX   PubMed=32623934;
WW   Provider; NCI TTC; TAB-4215/E-198-2018-0; https://techtransfer.cancer.gov/available-technologies?abstract=TAB-4215
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q8N158; Human GPC2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
RX   Patent=US12012463;
RA   Ho, Mitchell
RA   Li, Nan
RA   Fleming, Bryan D.
RT   "High affinity monoclonal antibodies targeting glypican-2 and uses
RT   thereof.";
RL   Patent number US12012463, 18-Jun-2024.
//
RX   PubMed=32623934; DOI=10.1369/0022155420933709; PMCID=PMC7711243;
RA   Li, Nan
RA   Spetz, Madeline R.
RA   Ho, Mitchell
RT   "The role of glypicans in cancer progression and therapy.";
RL   J. Histochem. Cytochem. 68:841-862(2020).
//